1. Study on the inhibitory effect of rocaglamide against Micropterus salmoides rhabdovirus (MSRV)
   Wenyan Zhang et al, 2023, Aquaculture CrossRef
2. Nucleofection optimization and in vitro anti-tumourigenic effect of TRAIL-expressing human adipose-derived mesenchymal stromal cells
   Kamal Shaik Fakiruddin et al, 2014, Cancer Cell International CrossRef
3. Activation and Inhibition of ATM by Phytochemicals: Awakening and Sleeping the Guardian Angel Naturally
   Ammad Ahmad Farooqi et al, 2015, Archivum Immunologiae et Therapiae Experimentalis CrossRef
4. Rocaglamide Prolonged Allograft Survival by Inhibiting Differentiation of Th1/Th17 Cells in Cardiac Transplantation
   Chen Dai et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
5. Solanum nigrum polysaccharide inhibits tumor growth in H22-bearing mice through regulation of caspase-3 and bcl-2
   Yueyan Huang et al, 2018, Journal of Cancer Research and Therapeutics CrossRef
6. TRAILblazing Strategies for Cancer Treatment
   Anna-Laura Kretz et al, 2019, Cancers CrossRef
7. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma
   Mei-Chuan Chen et al, 2016, Oncotarget CrossRef
8. Down‐regulation of intracellular anti‐apoptotic proteins, particularly c‐FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL
   Ali Hassanzadeh et al, 2018, Journal of Cellular Physiology CrossRef
9. Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells
   Eun Byeol Jo et al, 2019, BMC Cancer CrossRef
10. Regulation of extrinsic apoptotic signaling by c-FLIP: towards targeting cancer networks
    Nikita V. Ivanisenko et al, 2022, Trends in Cancer CrossRef
11. Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness
    Sangita Sridharan et al, 2019, Frontiers in Oncology CrossRef
12. Synthesis and Evaluation of the Antitumor Activity of Novel 1-(4-Substituted phenyl)-2-ethyl Imidazole Apoptosis Inducers In Vitro
    Zhen-Wang Li et al, 2020, Molecules CrossRef
13. Sensitization of renal carcinoma cells to TRAIL-induced apoptosis by rocaglamide and analogs
    Ancy D. Nalli et al, 2018, Scientific Reports CrossRef
14. Characterization of Plasmodium falciparum prohibitins as novel targets to block infection in humans by impairing the growth and transmission of the parasite
    Monika Saini et al, 2023, Biochemical Pharmacology CrossRef
15. The strong inhibitory effect of combining anti-cancer drugs AT406 and rocaglamide with blue LED irradiation on colorectal cancer cells
    Congwen Li et al, 2020, Photodiagnosis and Photodynamic Therapy CrossRef
16. Mitomycin C enhanced the antitumor efficacy of Rocaglamide in colorectal cancer
    Liguo Xie et al, 2023, Pathology - Research and Practice CrossRef
17. Panbinostat decreases cFLIP and enhances killing of cancer cells by immunotoxin LMB-100 by stimulating the extrinsic apoptotic pathway
    Xiu-Fen Liu et al, 2017, Oncotarget CrossRef
18. Targeted intervention of eIF4A1 inhibits EMT and metastasis of pancreatic cancer cells via c-MYC/miR-9 signaling
    Yuchong Zhao et al, 2021, Cancer Cell International CrossRef
19. Synthesis, activity evaluation, and pro-apoptotic properties of novel 1,2,4-triazol-3-amine derivatives as potent anti-lung cancer agents
    Xian-yu Sun et al, 2019, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef